Effects of synbiotic supplementation on inflammatory and anti-inflammatory markers in adults: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials
BioImpacts · 04.10.2026 · 16 · 32952
DOI: 10.34172/bi.32952 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift BioImpacts, online erschienen am 04.10.2026. Verfasst von Mohammad Vesal Bideshki und 10 weiteren Autor:innen. Die Arbeit nennt 120 Literaturangaben.
Abstract (Originalsprache)
Introduction
Systemic inflammation contributes to chronic diseases, and synbiotics may modulate these pathways via gut microbiota. This systematic review and meta-analysis evaluates synbiotic supplementation effects on adult inflammatory and anti-inflammatory markers.
Methods
A comprehensive search of PubMed/MEDLINE, Web of Science, Scopus, Embase, and CENTRAL, supplemented by Google Scholar and manual reference-list searches, identified 63 randomized controlled trials involving 3,725 participants. Eligible studies administered synbiotics for at least 3 weeks. Data were pooled using random-effects models to calculate standardized mean differences (SMDs). Risk of bias was assessed using the Cochrane risk-of-bias tool, and the certainty of evidence was evaluated using the GRADE approach.
Results
Synbiotic supplementation was associated with a reduction in C-reactive protein (CRP) (SMD: -0.49, 95% CI: -0.67 to -0.31), interleukin-6 (IL-6) (SMD: -0.33, 95% CI: -0.61 to -0.05), IL-8 (SMD: -0.62, 95% CI: -1.15 to -0.09), and tumor necrosis factor-α (TNF-α) (SMD: -0.38, 95% CI: -0.65 to -0.11). Conversely, anti-inflammatory IL-10 significantly increased (SMD: 0.30, 95% CI: 0.002 to 0.59). No significant changes occurred in IL-1β, IFN-γ, lipopolysaccharide (LPS), or adiponectin. Publication bias was detected for CRP, and evidence certainty ranged from very low to low.
Conclusion
Synbiotic appears to modulate inflammatory status by reducing key pro-inflammatory biomarkers (CRP, IL-6, IL-8, and TNF-α), and increasing the anti-inflammatory cytokine IL-10. Nevertheless, the strength of these conclusions is limited by the low to very low certainty of the available evidence, as well as potential publication bias affecting the CRP estimate. Future standardized, adequately powered RCTs are required to validate these clinical findings.
Zitieren
APA
Bideshki, M. V., Alamdari, N. M., Bahari, H., Asadi, Z., Sadeghi, B., Salehi, T., Jozi, H., Behzadi, M., Motlagh, S. F. Z., Sohrabi, Z., & Rashidinejad, A. (2026). Effects of synbiotic supplementation on inflammatory and anti-inflammatory markers in adults: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials. BioImpacts, 16, 32952. https://doi.org/10.34172/bi.32952
Vancouver
Bideshki MV, Alamdari NM, Bahari H, Asadi Z, Sadeghi B, Salehi T, et al. Effects of synbiotic supplementation on inflammatory and anti-inflammatory markers in adults: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials. BioImpacts. 2026;16:32952. doi:10.34172/bi.32952
BibTeX
@article{Bideshki2026,
author = {Bideshki, Mohammad Vesal and Alamdari, Naimeh Mesri and Bahari, Hossein and Asadi, Zahra and Sadeghi, Behrad and Salehi, Tohid and Jozi, Hannane and Behzadi, Mehrdad and Motlagh, Seyed Fazel Zinat and Sohrabi, Zahra and Rashidinejad, Ali},
title = {Effects of synbiotic supplementation on inflammatory and anti-inflammatory markers in adults: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials},
journal = {BioImpacts},
year = {2026},
volume = {16},
pages = {32952},
doi = {10.34172/bi.32952}
}
EUVIMED